BiomX Inc. (PHGE)
2025-06-30 | ||||
|---|---|---|---|---|
| Tax expenses | 2 | |||
| Other expenses (income) | -70 | |||
| Research and development (r&d) expenses, net | 5,014 | |||
| General and administrative expenses | 2,419 | |||
| Operating loss | -7,433 | |||
| Finance expense (income), net | -25 | |||
| Interest expenses | 5 | |||
| Income from change in fair value of warrants | -1,498 | |||
| Loss (income) before tax | -6,035 | |||
| Net loss (income) | -6,037 | |||
| Basic loss (earnings) per share of common stock (in dollars per share) | 0.19 | |||
| Diluted loss per share of common stock (in dollars per share) | 0.19 | |||
| Weighted average number of shares used in computing basic loss (earnings) per share of common stock (in shares) | 31,308,396 | |||
| Weighted average number of shares used in computing diluted loss per share of common stock (in shares) | 31,308,396 | |||